Ocular melanoma – Diagnostics – Overview of Information and Clinical Research

Getting a proper diagnosis of ocular melanoma is the first step toward understanding this rare eye cancer. Most people with this condition don’t experience symptoms at first, which is why regular eye exams are so important. The good news is that doctors can often diagnose ocular melanoma with great accuracy using non-invasive methods, without needing a biopsy in most cases.

Introduction: Who Should Get Tested and When

Ocular melanoma is most often discovered during a routine eye examination, even before a person notices anything wrong with their vision. This makes regular eye check-ups extremely important, especially for people over the age of 50, when the risk of this cancer increases. The average age at diagnosis is around 55 to 60 years old.^[1]^[4]

You should consider seeking an eye examination sooner rather than later if you notice any changes in your vision or eye appearance. These changes might include seeing flashes of light, noticing spots or specks floating in your vision (often called floaters, which are small particles that appear to drift across your field of view), experiencing blurred or poor vision in one eye, or observing a growing dark spot on the colored part of your eye. Some people also notice changes in the shape of their pupil, which is the dark circle at the center of the eye, or find they can’t see well when looking to the side, which doctors call loss of peripheral vision.^[1]^[8]

People with certain characteristics face higher risk and should be especially vigilant about regular eye exams. If you have light-colored eyes, such as blue or green, fair skin that burns easily, blonde or red hair, or many freckles or moles on your skin, you should pay special attention to your eye health. Unlike skin melanoma, ocular melanoma is not thought to be related to sun exposure, but fair-skinned individuals are more commonly affected.^[4]^[11]

⚠️ Important

Many people with ocular melanoma don’t experience any symptoms at all, especially in the early stages. This is because the cancer most often forms in parts of the eye you can’t see when looking in a mirror. That’s why routine dilated eye exams are your best defense against this disease. If you’re over 50 or have risk factors, make sure to schedule regular eye check-ups even if your vision seems fine.

If you’re already diagnosed with a small, inactive dark spot in your eye called a choroidal nevus (sometimes called an “eye freckle”), your eye doctor will want to monitor it over time. These spots occur in about 20 percent of the population and are usually harmless, but in rare cases they can develop into melanoma. Regular monitoring helps catch any concerning changes early.^[10]

Classic Diagnostic Methods

The good news about diagnosing ocular melanoma is that doctors can usually identify it with great accuracy without needing invasive procedures like biopsies. In fact, diagnosis is established by clinical examination alone in most cases, with high levels of certainty.^[3]^[11]

The Eye Examination

Your diagnostic journey typically begins with a comprehensive eye examination. The doctor will first examine the outside of your eye, looking for any unusual features such as blood vessels that are larger than normal. Enlarged blood vessels might indicate that something concerning is happening inside the eye.^[7]^[18]

The most important part of the exam involves looking inside your eye using specialized equipment. Your doctor will dilate your pupils using eye drops, which makes them wider and allows for a better view of the internal structures. This is crucial because most ocular melanomas develop in areas you cannot see when looking in a mirror.^[1]

Two main techniques help doctors see inside your eye. The first is called binocular indirect ophthalmoscopy, where the doctor uses special lenses and a bright light mounted on their forehead to examine the back of your eye. The second method is slit-lamp biomicroscopy, which uses a microscope with an intense beam of light to illuminate the inside of your eye in great detail.^[7]^[18]

Imaging Tests

Once your doctor spots something suspicious during the physical exam, several imaging tests help confirm the diagnosis and determine the size and characteristics of the tumor. These tests are painless and provide detailed information about what’s happening inside your eye.

Fundus photography involves taking color pictures of the inside surface of your eye, called the fundus. This test can clearly show an eye melanoma and can be repeated over time to track any changes in the tumor’s appearance. A variation called fundus autofluorescence uses special imaging to highlight certain features of the tumor.^[7]^[18]

Eye ultrasound is one of the most important diagnostic tools for ocular melanoma. This test uses high-frequency sound waves to create images of your eye’s internal structures. A healthcare professional places a small device that looks like a wand, called a transducer, either on your closed eyelid or on the front surface of your eye. The sound waves bounce off the structures inside your eye and create detailed pictures. Ultrasound is particularly helpful for measuring the height, length, and width of the tumor, which is critical for planning treatment.^[7]^[10]^[18]

Optical coherence tomography (OCT) is a laser-based imaging technique that provides detailed cross-sectional images of the eye’s layers. Think of it as similar to a CT scan, but using light waves instead of X-rays. OCT is especially useful for examining the macula, which is the central part of the retina responsible for sharp, detailed vision. This test helps doctors understand how the tumor might be affecting your vision.^[10]

Angiography tests examine the blood vessels in your eye. During fluorescein angiography, a colored dye is injected into a vein in your arm. The dye travels through your bloodstream to the blood vessels in your eye. A special camera with filters takes rapid pictures every few seconds, showing how blood flows through the eye and revealing abnormal patterns that might indicate cancer. A similar test called indocyanine green angiography uses a different dye to examine deeper blood vessel layers.^[7]^[10]^[18]

Advanced Imaging When Needed

In some cases, doctors may recommend additional imaging tests to get even more detailed information about the tumor or to check whether the cancer has spread beyond the eye.

Magnetic resonance imaging (MRI) uses powerful magnets and radio waves to create detailed pictures of your eye and the surrounding structures. Unlike X-rays or CT scans, MRI doesn’t use radiation. This test is particularly good at showing the soft tissues of the eye and can help distinguish ocular melanoma from other conditions that might look similar.^[11]

Computed tomography (CT) scans use X-rays taken from many different angles to create cross-sectional images of your body. While not always necessary for diagnosing the eye tumor itself, CT scans of the chest, abdomen, and pelvis might be ordered to check whether the cancer has spread to other parts of your body, particularly the liver, which is the most common site where ocular melanoma spreads.^[11]

When a Biopsy Might Be Necessary

Unlike most other types of cancer, ocular melanoma rarely requires a biopsy for diagnosis. A biopsy involves removing a small sample of tissue for examination under a microscope. Doctors can usually diagnose ocular melanoma accurately based on the clinical examination and imaging tests alone.^[3]^[8]^[11]

However, a biopsy may be performed in certain situations. If the diagnosis is uncertain and the tumor’s appearance is unusual, a small tissue sample might help confirm whether it’s truly melanoma. More importantly, even when the diagnosis is clear, doctors may take a biopsy during treatment to obtain tumor tissue for genetic testing. This genetic information helps predict how the tumor might behave and whether it’s likely to spread, which is crucial for planning long-term monitoring and potential future treatments.^[10]^[11]

Distinguishing Ocular Melanoma from Other Conditions

One important purpose of diagnostic testing is to make sure the dark spot in your eye is actually melanoma and not something else. Several other conditions can look similar to ocular melanoma, and distinguishing between them is crucial for appropriate treatment.

For tumors in the choroid (the vascular layer at the back of the eye), doctors need to rule out other possibilities such as benign choroidal nevi (harmless eye freckles), metastatic tumors that spread from cancers elsewhere in the body, benign blood vessel growths called hemangiomas, and bone-like growths called osteomas. Bleeding conditions and inflammatory diseases can also sometimes mimic the appearance of melanoma.^[6]

When a tumor appears on the iris (the colored part of your eye), doctors will consider whether it might be a harmless iris nevus, various types of cysts, tumors that have spread from elsewhere, or other rare eye conditions rather than true melanoma.^[6]

⚠️ Important

If you receive a diagnosis of ocular melanoma, consider seeking a second opinion from an ocular oncologist or a specialized eye cancer center. These specialists have extensive experience with this rare cancer and can confirm your diagnosis, help you understand your options, and ensure you receive the most appropriate care. Because ocular melanoma is uncommon, most community eye doctors may see very few cases in their careers, so specialist consultation is valuable.

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial for ocular melanoma, you’ll likely need to undergo specific diagnostic tests beyond those used for initial diagnosis. Clinical trials have strict entry criteria to ensure participant safety and to make sure the trial results are reliable and meaningful.

Tumor Characterization and Staging

Clinical trials typically require detailed information about your tumor’s size, location, and characteristics. Your ocular oncologist will use the measurements obtained from ultrasound and other imaging tests to stage your cancer. Staging is a process that defines the extent of your tumor based on its dimensions and other features.^[10]

Historically, doctors used a system called the Collaborative Ocular Melanoma Study (COMS) to classify tumors as small, medium, or large based on their measurements. More recently, the staging system has been updated to the Eighth Edition American Joint Committee on Cancer (AJCC) Cancer Staging Manual, which incorporates multiple factors beyond just size. These staging systems help match patients to appropriate clinical trials.^[10]^[11]

Genetic Testing of the Tumor

Many modern clinical trials for ocular melanoma require genetic testing of the tumor tissue. This testing examines the DNA and chromosomes inside the tumor cells to identify specific mutations or changes that might predict how the cancer will behave. Some genetic changes indicate tumors with high risk of spreading to other parts of the body, while others suggest lower risk.^[3]^[10]

To obtain tissue for genetic testing, doctors may perform a fine needle biopsy at the time of treatment. This involves inserting a very thin needle into the tumor to extract a small sample of cells. The procedure is usually done during another treatment procedure, such as when placing a radiation plaque or during surgery. The tissue sample is then sent to a specialized laboratory for genetic analysis.^[10]

Understanding your tumor’s genetic profile is increasingly important not just for clinical trial eligibility, but also for predicting your prognosis and planning appropriate monitoring schedules. Tumors with certain genetic patterns are more likely to spread and may benefit from more frequent surveillance testing.^[3]

Screening for Metastatic Disease

Before enrolling in certain clinical trials, especially those testing new treatments for advanced disease, you’ll need thorough testing to determine whether the cancer has spread beyond your eye. This is called metastatic screening or staging workup.^[10]

Because ocular melanoma most commonly spreads to the liver, screening often focuses on liver imaging. This might include liver ultrasound, CT scans of the abdomen, or MRI of the liver. Blood tests that measure liver function may also be performed. Some trials may require PET scans (positron emission tomography) or other imaging of the entire body to check for cancer spread to other organs.^[11]

General Health Assessment

Clinical trials also require confirmation that you’re healthy enough to participate and can safely undergo the experimental treatments being tested. This typically involves standard blood tests to check your blood cell counts, liver function, kidney function, and other basic health markers. You might need an electrocardiogram (EKG) to check your heart function, especially if the trial involves treatments that could affect the heart.^[10]

Your doctors will also review your complete medical history and any other medications you’re taking. Some clinical trials exclude patients with certain other health conditions or those taking specific medications that might interfere with the experimental treatment.

Baseline Vision Assessment

Many clinical trials for eye cancer require detailed documentation of your vision before treatment begins. This baseline assessment allows researchers to track how the treatment affects your eyesight over time. You might undergo standard vision tests, such as reading eye charts, as well as more specialized tests of your visual field (how much you can see to the sides while looking straight ahead) and color vision.

These tests are usually painless and straightforward, but they’re important for understanding both the safety and effectiveness of new treatments being studied in clinical trials.

Prognosis and Survival Rate

Prognosis

The outlook for people with ocular melanoma depends on several factors, including the size and location of the tumor, its genetic characteristics, and whether it has spread to other parts of the body. Location matters significantly: melanomas of the iris tend to have the best prognosis, while tumors of the ciliary body have the worst. Most uveal melanomas originate in the choroid, which has an intermediate prognosis.^[6]

The size of the tumor also affects your outlook. Smaller tumors that are caught early and treated promptly generally have better outcomes. However, even with successful treatment of the tumor in the eye, ocular melanoma carries a significant risk of spreading. Researchers estimate that in patients who eventually develop metastatic disease, tiny undetectable tumor cells may have already begun circulating in the bloodstream two to three years before the eye tumor was even treated.^[4]

Genetic testing of the tumor provides important information about prognosis. Recent advances in understanding the genetic changes within ocular melanoma cells have enhanced doctors’ ability to predict which tumors have high metastatic potential (meaning they’re more likely to spread) and which ones are lower risk. Despite complete control of the primary tumor in the eye, the cancer eventually spreads to other parts of the body in approximately 40 to 50 percent of patients. When the cancer spreads, the liver is the most common destination.^[3]^[4]

The good news is that local treatment of the tumor in the eye has improved considerably, with more options now available to preserve the eye and maintain some vision. Many people diagnosed with ocular melanoma go on to live long and healthy lives, especially those who are proactive about their care and maintain healthy lifestyles. However, because of the risk of spread, lifelong monitoring is essential even after successful treatment of the eye tumor.^[13]^[20]

Survival Rate

Understanding survival rates can help you have informed conversations with your doctors, though it’s important to remember that statistics describe large groups of people and cannot predict exactly what will happen to any individual person. Your own outlook depends on your specific situation.

Unfortunately, when ocular melanoma spreads to other parts of the body, the prognosis becomes much more challenging. The five-year survival rate for patients whose eye melanoma has spread to distant parts of the body is about 15 percent.^[6] This means that approximately 15 out of every 100 people with metastatic ocular melanoma are still alive five years after diagnosis. Metastatic disease remains the leading cause of death among patients with uveal melanoma, primarily because there is currently no highly effective systemic therapy for widespread disease, though research in this area is very active.^[3]

The timing of metastasis is also important to understand. Most patients show no evidence of metastatic disease at the time their eye tumor is diagnosed. Clinical metastases (meaning cancer that can be detected with tests) usually develop years after the diagnosis and treatment of the primary eye tumor. This delayed pattern makes long-term surveillance critically important.^[4]

Despite these sobering statistics about advanced disease, survival rates for ocular melanoma have remained stable over recent decades, and many patients with early-stage disease do very well. The incidence of uveal melanoma has not increased over the past few decades, unlike cutaneous (skin) melanoma, which has been rising. This stable pattern affects approximately 5 to 6 cases per million people per year in light-skinned populations.^[4]

It’s worth emphasizing that new treatments are being developed and tested in clinical trials, offering hope for improved outcomes in the future. Better understanding of the genetic and molecular changes that drive ocular melanoma is opening doors to targeted therapies that may eventually improve survival rates, particularly for patients with metastatic disease.^[3]

#1 Clinical Trials Search in Europe